Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: New York
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

WuXi PharmaTech Cayman Inc

+ Add to Watchlist

WX:US

43.5000 USD 0.1300 0.30%

As of 20:04:06 ET on 05/22/2015.

Snapshot for WuXi PharmaTech Cayman Inc (WX)

Open: 43.7900 Day's Range: 43.3300 - 43.9500 Volume: 221,273
Previous Close: 43.6300 52wk Range: 30.3800 - 46.1400 1-Yr Rtn: +24.50%

Stock Chart for WX

No chart data available.
  • WX:US 43.5000
  • 1D
  • 1M
  • 1Y
43.6300
Interactive WX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for WX

Current P/E Ratio (ttm) 30.8851
Estimated P/E(12/2015) 24.6739
Relative P/E vs. SPX 1.6440
Earnings Per Share (USD) (ttm) 1.4084
Est. EPS (USD) (12/2015) 1.7630
Est. PEG Ratio 1.8054
Market Cap (M USD) 3,111.72
Shares Outstanding (M) 71.53
30 Day Average Volume 663,316
Price/Book (mrq) 3.8460
Price/Sale (ttm) 4.3151
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for WX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for WX

WuXi PharmaTech (Cayman), Inc. provides research services. The Company offers services include researching, analysis, development, and manufacturing of pharmaceutical and biotechnology products.

Ge LiChairman/CEO/Co-FounderEdward Hu "Ed"CFO/Chief Invsmt Officer
Shuhui ChenChief Scientific OfficerSteve YangExec VP/COO
More Company Profile & Key Executives for WX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil